We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Project Aims To Develop Molecular Diagnostics Solution

By LabMedica International staff writers
Posted on 24 Jun 2010
A three-year project aims to develop an integrated software and hardware solution for molecular diagnostics.

The molecular diagnostics solution will intelligently use the fast and cheap sequencing options that the high-throughput sequencing industry provides, to diagnose rapidly and more precisely patient DNA samples through advanced, user-friendly software.

CLC bio (Aarhus N, Denmark), Ion Torrent (Guilford, CT, USA), and Aarhus University Hospital (Skejby, Denmark) have received a US$2 million grant from the Danish National Advanced Technology Foundation for the project.

Ion Torrent's ion personal genome machine (PGM) sequencer does a single run in about an hour or two, which makes the simple, yet scalable technology ideal for this molecular diagnostics project, where time is a critical factor in the patient diagnosis phase.

Roald Forsberg, Ph.D., director of scientific development at CLC bio said, "With our bioinformatics software solutions, we have succeeded in making advanced high-throughput sequencing technologies accessible to biomedical researchers. More...
Now we want to bring the DNA sequencing revolution to the hospitals and clinics, in order to realize the huge potential of high-throughput sequencing within molecular diagnostics, and personalized- and translational medicine."

The project will lead to an IT solution that can be used for clinical diagnostics in hospitals and outpatient clinics as well as for molecular diagnostics research.

Related Links:
CLC bio
Ion Torrent
Aarhus University Hospital
Danish National Advanced Technology Foundation



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.